How can point-of-care technologies support in-hospital diabetes care?
Open accessAbstract
People with diabetes admitted to hospital are at risk of diabetes related complications including hypoglycaemia and diabetic ketoacidosis. Point-of-care (POC) tests undertaken at the patient bedside, for glucose, ketones, and other analytes, are a key component of monitoring people with diabetes, to ensure safety. POC tests implemented with a quality framework are critical to ensuring accuracy and veracity of results and preventing erroneous clinical decision making. POC results can be used for self-management of glucose levels in those well-enough and/or by healthcare professionals to identify unsafe levels. Connectivity of POC results to electronic health records further offers the possibility of utilising these results proactively to identify patients ‘at risk’ in real-time and for audit purposes. In this article, the key considerations when implementing POC tests for diabetes in-patient management are reviewed and potential to drive improvements using networked glucose and ketone measurements are discussed. In summary, new advances in POC technology should allow people with diabetes and the teams looking after them whilst in hospital to integrate to provide safe and effective care.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The balance between analytic requirements (e.g., accuracy, precision, and interference) and clinical requirements (e.g., rapidity, simplicity, and POC) has not been uniformly resolved, and most hospitals have arrived at their own policies to balance these parameters.
“The balance between analytic requirements (e.g., accuracy, precision, and interference) and clinical requirements (e.g., rapidity, simplicity, and POC) has not been uniformly resolved (39)(40)(41)(42), and most hospitals have arrived at their own policies to balance these parameters.”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [42]
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0303 · Cited by 102 · see citing works
Rushakoff, R. J., Sullivan, M. M., MacMaster, H. W., Shah, A. D., Rajkomar, A., Glidden, D. V., & Kohn, M. A. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1413 · Cited by 91 · see citing works
Flagged first, then by citations
Research works printed but not linked: 33
- Rajendran R, Rayman G. Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review. J Diabetes Sci Technol. 2014;8(6):1081-1090.
- Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;2(2):95- 108.
- Price CP. Point of care testing. Br Med J. 2001;322(7297):1285- 1288. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120384/.
- Huckle D. Point-of-care diagnostics-is this driven by sup- ply or demand? Expert Opin Med Diagn. 2010;4(3):189-200. doi:10.1517/17530051003671556. · DOI
- St John A. The evidence to support point-of-care testing. Clin Biochem Rev. 2010;31(3):111-119. http://www.ncbi.nlm.nih .gov/pmc/articles/PMC2924123/.
- Hermayer KL, Loftley AS, Reddy S, Narla SN, Epps NA, Zhu Y. Challenges of inpatient blood glucose monitoring: stan- dards, methods, and devices to measure blood glucose. Curr Diab Rep. 2015;15(3):10. doi:10.1007/s11892-015-0582-9. · DOI
- Avari P, Lumb A, Flanagan D, Rayman G, Misra S, Choudhary P, & Dhatariya K. Continuous Glucose Monitoring within hospital: A scoping Review and Summary of the Guidelines from the Joint British Diabetes Societies for Inpatient Care. J Diabetes Sci Technol. 2022. doi:10.1177/19322968221137338. · DOI
- Misra S, Oliver NS. Utility of ketone measurement in the pre- vention, diagnosis and management of diabetic ketoacidosis. Diabet Med. 2015;32(1):14-23.
- Dhatariya K. Blood ketones: measurement, interpretation, lim- itations, and utility in the management of diabetic ketoacidosis. Rev Diabet Stud. 2016;13(4):217-225.
- Taboulet P, Haas L, Porcher R, et al. Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of keto- acidosis in the Emergency Department setting. Eur J Emerg Med. 2004;11(5):251-258. http://www.ncbi.nlm.nih.gov/ pubmed/15359197.
- Voulgari C, Tentolouris N. The performance of a glucose- ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room. Diabetes Technol Ther. 2010;12(7):529-535. doi:10.1089/dia.2010.0011. · DOI
- Charles RA, Bee YM, Eng PH, Goh SY. Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emer- gency department. Singapore Med J. 2007;48(11):986-989. http://www.ncbi.nlm.nih.gov/pubmed/17975686.
- Dhatariya KK, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med. 2022;39(6):e14788. doi:10.1111/ dme.14788. · DOI
- Umpierrez GE, Watts N, Phillips L. Clinical utility of β3-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis. Diabetes Care. 1995;18:137-138.
- Guerci B, Benichou M, Floriot M, et al. Accuracy of an elec- trochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after con- tinuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care. 2003;26(4):1137-1141.
- Chiu RW, Ho CS, Tong SF, Ng KF, Lam CW. Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration. Hong Kong Med J. 2002;8(3):172-176.
- Byrne HA, Tieszen KL, Hollis S, Dornan TL, New JP. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care. 2000;23(4):500-503.
- Khan AS, Talbot JA, Tieszen KL, Gardener EA, Gibson JM, New JP. Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance. Diabet Med. 2004;21(7):782-785.
- Yu HY, Agus M, Kellogg MD. Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patients. Pediatr Diabetes. 2011;12(7):649-655. doi:10.1111/j.1399- 5448.2011.00768.x. · DOI
- Savage MW, Dhatariya KK, Kilvert A, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28(5):508-515. http://www .ncbi.nlm.nih.gov/pubmed/21255074.
- Magee MF, Nassar C. Hemoglobin A1c testing in an emer- gency department. J Diabetes Sci Technol. 2011;5(6):1437- 1443. http://www.ncbi.nlm.nih.gov/pubmed/22226261.
- Gomez-Peralta F, Abreu C, Andreu-Urioste L, et al. Point-of- care capillary HbA1c measurement in the emergency depart- ment: a useful tool to detect unrecognized and uncontrolled diabetes. Int J Emerg Med. 2016;9(1):7. http://www.ncbi.nlm .nih.gov/pubmed/26894895.
- Inoue S, Egi M, Kotani J, Morita K. Accuracy of blood- glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care. 2013;17(2):R48. http://www.ncbi.nlm.nih.gov/ pubmed/23506841.
- Carlson DA. Point of care testing: regulation and accreditation. Clin Lab Sci. 1996;9(5):298-302; quiz 303-4.
- Misra S, Huddy J, Hanna G, Oliver N. Validation and regu- lation of point of care devices for medical applications. In: Narayan RJ, ed., Medical Biosensors for Point of Care (POC) Applications. Duxford, England: Woodhead Publishing; 2016: 27-44.
- Topic E, Nikolac N, Panteghini M, et al. How to assess the quality of your analytical method. Clin Chem Lab Med. 2015;53(11):1707-1718. https://www.degruyter.com/view/j/ cclm.2015.53.issue-11/cclm-2015-0869/cclm-2015-0869.xml.
- Stavelin A, Petersen PH, Søvik UØ, Sandberg S. External qual- ity assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable con- trol materials. Clin Chem. 2013;59(2):363-371. http://www .clinchem.org/content/59/2/363.abstract.
- Armbruster DA, Pry T. Limit of blank, limit of detec- tion and limit of quantitation. Clin Biochem Rev. 2008;29 (Suppl. 1):S49-S52. http://www.ncbi.nlm.nih.gov/pmc/arti cles/PMC2556583/.
- Lumb et al. Variation in the current use of technology to sup- port diabetes management in UK hospitals: Results of a survey of healthcare professionals. J Diabetes Sci Technol. https://doi. org/10.1177/19322968231161076. · DOI
- Sheen YJ, Huang CC, Huang SC, et al. Implementation of an electronic dashboard with a remote management system to improve glycemic management among hospitalized adults. Endocr Pract. 2020;26(2):179-191.
- Kyi M, Colman PG, Rowan LM, Marley KA, Wraight PR, Fourlanos S. Glucometric benchmarking in an Australian hos- pital enabled by networked glucose meter technology. Med J Aust. 2019;211(4):175-180.
- Pichardo-Lowden A, Umpierrez G, Lehman EB, et al. Clinical decision support to improve management of dia- betes and dysglycemia in the hospital: a path to optimiz- ing practice and outcomes. BMJ Open Diabetes Res Care. 2021;9(1):e001557.
- Cheung NW, Hor A, Hng T-M. The virtual inpatient diabetes management service: COVID-19 brings the future to inpatient diabetes management. Med J Aust. 2022;216:321-322.
Cited by
Sorted by citations
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s016 · Cited by 80 · see citing works
- Authors
- Misra, S., Avari, P., Lumb, A., Flanagan, D., Choudhary, P., Rayman, G., & Dhatariya, K.
- Affiliations
- Imperial College Healthcare NHS Trust (GB)
- Churchill Hospital (GB)
- Plymouth Hospital (GB)
- University of Leicester (GB)
- East Suffolk and North Essex NHS Foundation Trust (GB)
- University of East Anglia (GB)
- Corresponding author
- Misra, Shivani
- ORCID
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2023-02-21
- Volume
- 17
- Issue
- 2
- Pages
- 509-516
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC10012370
- OpenAlex
- W4321498361
- Cited by
- 9
- References
- 2
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Wellcome Trust
- Insulet Corporation
- Dexcom
- National Institute for Health and Care Research
- Imperial College London
- Imperial College Healthcare NHS Trust
- Novo Nordisk
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- point-of-care testing, hypoglycemia, diabetic ketoacidosis, glucose monitoring, electronic health records, quality framework, patient safety, risk identification
- MeSH terms
- Point-of-Care Testing, Diabetes Mellitus, Glucose, Hospitals, Humans, Diabetic Ketoacidosis, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
